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Abstract
Background. Qualifying the relationship between multi-morbidity, health-related quality of life 
(HRQOL) and depressive symptoms in primary care can help to inform the development of appropriate 
interventions and services which can help to enhance HRQOL in patients with chronic disease.
Objective. The objective of this study was to determine whether the physical aspect of HRQOL 
mediates the relationship between chronic disease multi-morbidity and depressive symptoms in 
Chinese primary care patients.
Methods. A cross-sectional survey was conducted on patients recruited from the waiting rooms of 
59 primary care clinics distributed across Hong Kong. About 9259 subjects were included for the 
mediation model analysis. The primary outcome was level of depressive symptoms as measured by 
the Patient Health Questionniare 9. The mediation model was tested using a bootstrapping method.
Results. The prevalence of chronic disease was 50.4%, with 25.4% having two or more co-
morbidities. The relationship between multi-morbidity and depressive symptoms was found to be 
mediated by the Physical Component Summary score of the SF-12 v2. Further analysis found the 
general health (GH) and role physical domains of the SF-12 were the strongest mediators, followed 
by bodily pain and physical functioning (PF).
Conclusion. To enhance the functional capacity of primary care patients with co-existing chronic 
disease and depressive symptoms, health care interventions should be directed at improving the 
physical aspects of HRQOL, in particular enhancing patients’ GH perception, role functioning and 
PF, and to better manage chronic pain.
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Introduction
Co-morbidity of chronic disease and depression is very common (1). 
The association between physical health and emotional symptoms is 
thought to be related to the loss in the functional capacity to conduct 
routine daily activities (2–4). It has been postulated that physical illness 
affects mental health via biological mechanisms (e.g. hormonal change 
and side effects of treatments), behavioural pathways (e.g. disruption 
of daily routines and sick role behaviours), cognitive effects (e.g. per-
ceived stress and locus of control) and social interference (e.g. impedi-
ment of usual role functioning or deterioration of social networks) (5).
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The medical management of multi-morbidity is challenging 
because patients with chronic disease often require complicated treat-
ments (4) and have poor health outcomes. Multi-morbidity can also 
impact health-related quality of life (HRQOL) (6). Previous studies 
have found that people with more chronic physical disease are at a 
higher risk of having major depression (3). With population ageing, it 
is expected that as the prevalence of chronic disease increases, there 
will be a concomitant increase in the prevalence of depression (7).
A study conducted in Australia by Gunn et al. (8) found a dose–
response relationship between the number of chronic physical problems 
and severity of depressive symptoms, and that the relationship was 
potentially mediated by two aspects of HRQOL (functional limitation 
and self-rated health). In that study, a regression analysis was used to 
explore the relationship which is not robust enough to confirm if a 
mediation model exists. Also, only two questions were used to measure 
physical HRQOL which may oversimplify the construct. The study was 
conducted in a western setting and the findings may not be transferable 
to Asian settings where health beliefs and health systems are different.
In recent decades, there has been a shift in chronic disease man-
agement away from specialist settings to primary care. Primary care 
clinicians are trained to use a patient-centred, holistic management 
approach are well placed to coordinate the multi-disciplinary care 
often required by patients with chronic disease (9). A better under-
standing of the relationship between multi-morbidity, HRQOL and 
depressive symptoms can help primary care doctors to better man-
age patients with chronic disease by informing the development of 
interventions that can address their multi-dimensional needs. The 
aim of this study was to determine whether the physical aspects of 
HRQOL mediated the relationship between multi-morbidity and 
depressive in a Chinese primary care patient population.
Methods
To further and strengthen the findings by Gunn et al. (10), we chose a 
bootstrapping method approach to explore the relationship between 
multi-morbidity, HRQOL and depressive symptoms, using a well-
validated HRQOL measure to assess the physical aspects of HRQOL.
Design
This study was conducted as part of an observational study exam-
ining the epidemiology of depressive disorders in Hong Kong’s 
primary care (11,12). Data obtained from a cross-sectional survey 
was analysed to explore the association between multi-morbidity, 
HRQOL and depressive symptoms.
Subjects and sampling
Doctors working in primary care clinics located across Hong Kong 
were identified from the 1500-member mailing list of the Hong Kong 
College of Family Physicians and invited to join our practice-based 
research network. A total of 59 doctors voluntarily joined the study: 
11 from public-sector clinics and 48 from private practice settings, 
Figure 1. The proposed mediation models
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aligning proportionately with the delivery of primary care services in 
Hong Kong. All eligible patients presenting to the study doctor on 
one randomly selected day each month over 1 year were consecutively 
recruited to join the study. Patients were approached in the doctor’s 
waiting room by field workers and excluded if they were (1) aged < 
18 years (2), could not understand English, Cantonese or Mandarin 
(3), had cognitive or communication difficulties (4), had already 
been recruited to the study and (5) did not consult the study doctor. 
A 12-month collection period was used to account for seasonal varia-
bility and to improve the representation of the primary care case load. 
Data collection occurred between October 2010 and January 2012.
Study instruments
Subjects completed a waiting-room questionnaire containing items 
on socio-demographics, a checklist of chronic health conditions, the 
Patient Health Questionnaire 9 (PHQ-9), and the Short Form-12 
Health Survey version 2 (SF-12 v2).
Multi-morbidity
To assess the prevalence of chronic disease, subjects were asked if 
they had ever been diagnosed by a doctor to have hypertension, dia-
betes mellitus, heart disease, stroke, chronic respiratory disease (such 
as asthma, chronic bronchitis and emphysema), arthritis or other 
chronic rheumatism, chronic pain and other major diseases. This list 
was adapted from previously performed primary care patient studies 
(13) and included the most common chronic conditions encountered 
in Hong Kong’s primary care (14). The number of chronic diseases 
was calculated by counting the number of conditions selected.
PHQ-9
The PHQ-9 is a 10-item self-report depression scale which scores 
each of the nine Diagnostic and Statistical Manual of Mental 
Disorders, 4th Edition (DSM-IV) criteria for a diagnosis of major 
depression episode plus an extra item on functional difficulties as a 
result of the depressive symptoms. The total score ranged from 0 to 
27, with higher score indicating more severe symptoms. It has been 
validated on primary care patients in Hong Kong. Using a cut-off 
score of >9, the PHQ-9 has been found to have a sensitivity of 80% 
and specificity of 92% for diagnosing depressive disorders against 
the Chinese Hamilton Depression Scale (15).
The Chinese (HK) SF-12 health survey version 2 
(SF-12 v2)
The SF-12 v2 is a generic HRQOL measure, which covers eight 
domains namely physical functioning (PF), role limitation due to 
Table 1. Baseline subject characteristics and prevalence of multi-morbidity (n = 9259)
Demographic characteristics Prevalence of chronic physical illness by type and number of 
conditions (n, %)
Age (median, IQR) 48 29
Gender (n, %) Hypertension 2589 28.0
 Male 3898 42.1 Diabetes mellitus 963 10.4
 Female 5352 57.8 Heart disease 487 5.3
 Missing 9 0.1 Stroke 143 1.5
Educational attainment (n, %) Chronic respiratory disease 706 7.6
 No formal school 715 7.7 Arthritis or other chronic rheumatism 1502 16.2
 Primary 1507 16.3 Chronic pain 1168 12.6
 Secondary (including matriculation) 3816 41.2 Other major diseases 943 10.2
 Tertiary 3151 34.0
 Missing 70 0.8
Marital status (n, %) Median number of multi-morbidities (IQR) 1 2
 Single 2531 27.3 Prevalence of multi-morbidity (n, %)
 Married 5633 60.8  No condition 4592 49.6
 Widow(er) 726 7.8  One condition 2317 25.0
 Separated or divorced 295 3.2  Two conditions 1363 14.7
 Missing 74 0.8  Three conditions 622 6.7
Employment status (n, %)  Four conditions 260 2.8
 Working 5698 61.5  Five conditions 82 0.9
 Not working 3498 37.8  Six conditions 20 0.2
 Missing 63 0.7  Seven conditions 2 0.022
 Eight conditions 1 0.011
Depressive symptoms and HRQOL Median IQR
PHQ-9 total score 3 5
SF-12 v2
 Physical functioning 100 25
 Role physical 87.5 25
 Bodily pain 75 50
 General health 25 35
 Vitality 75 25
 Social functioning 100 25
 Role emotional 87.5 25
 Mental health 75 25
 Physical component summary 49.9 10.6
 Mental  component summary 54.9 10.8
HRQOL, health-related quality of life; IQR, interquartile range; SD, standard deviation.
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physical problems (RP), bodily pain (BP), general health (GH), vital-
ity (VT), social functioning (SF), role limitation due to emotional 
problems (RE) and mental health (MH). The domain scores are cal-
culated by summation of the relevant item scores and transformation 
into a range from 0 to 100. The SF-12 v2 can be summarized into 
physical and mental component summary (PCS and MCS) scores 
with higher scores indicating better HRQOL. Its psychometric prop-
erties have been evaluated on a sampled of 2410 Chinese adults ran-
domly selected from the general population of Hong Kong and found 
to be a valid and equivalent substitute for the SF-36 version 2 Health 
Survey for the Chinese (16).
Statistical analysis
We used mediation analysis, applying the bootstrapping method 
to explore the relationship between multi-morbidity, depressive 
symptoms and HRQOL (10). This approach is considered to be 
more powerful than the Baron and Kenney’s multistage regression 
approach and the Sobel test for estimating mediation and indirect 
effects (17). Point estimates were based on 5000 bootstrapping 
samples and 95% confidence intervals (CI) were generated. An indi-
rect effect (multi-morbidity affects the physical aspects of HRQOL, 
which in turn affects depressive symptoms) was considered signifi-
cant if the CI did not contain zero.
The SF-12 v2 PCS was first used as the mediator. To further explore 
the impact of HRQOL on the relationship between multi-morbidity 
and depressive symptoms, the PF, RP, BP and GH domains were simul-
taneously used in the mediation analysis to allow comparison of the 
strength of the mediation effects (contrast) of each domain. As there 
were four mediators, there were six possible pairwise contrasts.
In order to overcome the potential effect of confounders, socio-
demographic factors including age, gender, educational attainment, 
marital status and employment status were adjusted for in the analy-
ses. Listwise deletion was used to handle the missing data.
The proposed mediation models are shown in Figure 1. Figure 1A 
shows the effect of multi-morbidity on depressive symptoms, without 
considering any mediators. In Figure 1B, a is the coefficient for multi-
morbidity in a model predicting the physical component of HRQOL 
from multi-morbidity, and b and c′ are the coefficients in a model pre-
dicting depressive symptoms from the physical component of HRQOL 
and multi-morbidity. c′ quantifies the direct effect of multi-morbidity on 
depressive symptoms, whereas the product of a and b (point estimate) 
quantifies the indirect effect of multi-morbidity on depressive symptoms 
through the physical component of HRQOL. In other words, c = c′ + 
ab. The indirect effect, ab, is the difference between the total and direct 
effect of multi-morbidity: ab = c – c′. The product ab can be clinically 
interpreted as the amount by which depressive symptoms are expected 
Figure 2. Models showing the effect of multimorbidity on depressive symptoms as mediated by the SF-12 v2
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to change indirectly through HRQOL per a unit change in multi-mor-
bidity. Figure 1C shows the proposed mediation model with multiple 
mediators. The specific indirect effect of multi-morbidity on depressive 
symptoms through one of the mediators is quantified as anbn (point esti-
mate). The total indirect effect of multi-morbidity on depressive symp-
toms is the sum of the specific indirect effects (a1b1 + a2b2 + a3b3 + a4b4). 
The total effect can be expressed as c = c′ + a1b1 + a2b2 + a3b3 + a4b4.
The ratio of the indirect effect to the total effect was used to quantify 
the effect size of the mediation model (PM). The proportion mediated is 
a frequently used effect-size measure. This measure indicated what pro-
portion of the total effect is mediated by the intervening variable. The 
proportion mediated also assessed the relative contribution of single 
mediators in multiple mediator models by indicating what proportion 
of the total effect is attributable to individual mediational pathways.
P = ab / (ab+c )M ¢
All significance tests were two-tailed with P < 0.05 considered sta-
tistically significant. All statistical analysis were performed using 
STATA Version 13.0.
Results
Sample characteristics
A total of 10 179 subjects completed the survey at baseline (response 
rate of 81.0%). About 920 subjects had missing data in multi-mor-
bidity, SF-12 v2 or PHQ-9. As a result, the data of 9259 subjects were 
included for unadjusted analysis. Of these, 9028 subjects who had 
the entire socio-demographic record were included for the adjusted 
analysis. Table 1 shows the socio-demographics, PHQ-9 and SF-12 
v2 scores, and the prevalence of chronic disease by condition and 
number of co-morbidities. The prevalence of chronic disease was 
50.4% of subjects with 25.4% having two or more chronic physical 
conditions. The most commonly reported chronic physical condi-
tions were hypertension (28.0%), arthritis or other chronic rheuma-
tism (16.2%), chronic pain (12.6%) and diabetes mellitus (10.4%).
The effect of HRQOL as measured by the SF-12 v2 
PCS, controlling for sociodemographics
After controlling for the SF-12 v2 PCS score, the direct effect of multi-
morbidity on depressive symptoms remained statistically significant (P 
< 0.01) (Figure 2). The bootstrapping method showed that the 95% 
CI (corrected for bias) did not contain zero (point estimate: 0.3365; 
95% CI: 0.2962–0.3806) (Table 2), supporting a partial mediation 
model. Multi-morbidity was associated with depressive symptoms 
both directly as well as through the physical components of HRQOL. 
Clinically, subjects with one unit change in multi-morbidity would 
have 0.34-point change in depressive symptoms through the physi-
cal component of HRQOL (indirect effect), and 0.55-point change in 
depressive symptoms directly (direct effect). In other words, PHQ-9 
score is expected to increase by 0.89-point (0.34-point through physi-
cal component of HRQOL and 0.55-point by direct effect) for every 
one-unit increase in multi-morbidity. The effect size was 0.38 suggest-
ing that the indirect effect accounted for 38% of the total effect.
The effects of HRQOL as measured by the SF-
12 v2 PF, RP, BP and GH controlling for socio-
demographics
After simultaneously controlling for the SF-12 v2 PF, RP, BP and GH, 
the direct effect of multi-morbidity on depressive symptoms remained 
statistically significant (P < 0.01) (Figure  3). The bootstrapping 
method showed that the 95% CI (corrected for bias) did not contain 
zero, indicating that the indirect effect of multi-morbidity on depres-
sive symptoms through the SF-12 v2 PF(point estimate: 0.0425; 95% 
CI: 0.0203–0.0667; effect size: 0.16), RP(point estimate: 0.2109; 95% 
CI: 0.1781–0.2474; effect size: 0.49), BP (point estimate: 0.1663; 95% 
CI: 0.1372–0.1967; effect size: 0.43) and GH (point estimate: 0.2458; 
95% CI: 0.2201–0.2732; effect size: 0.53) were all valid whilst adjust-
ing for the other domains (Table 2), supporting a partial mediation 
Table  2. The mediation effect (indirect effects) of HRQOL on the 
relationship between multi-morbidity and depressive symptoms 
by the bootstrapping method
The unadjusted mediation effect
Bias corrected 95% CIa
Point estimate Lower Upper
The SF-12 v2
 PCS 0.3404 0.3030 0.3819
 PF 0.0241 −0.0009 0.0499
 RP 0.0601 0.0327 0.0871
 BP 0.0955 0.0775 0.1168
 GH 0.2322 0.2084 0.2564
Comparing the strength of the mediators (indirect effects)
Bias corrected 95% CIb
Point estimate Lower Upper
 PF versus RP −0.0360 −0.0753 0.0018
 PF versus BP −0.0714 −0.1059 −0.0388
 PF versus GH −0.2081 −0.2426 −0.1708
 RP versus BP −0.0354 −0.0621 −0.0075
 RP versus GH −0.1721 −0.2042 −0.1385
 BP versus GH −0.1366 −0.1671 −0.1061
The adjusted mediation effectc
Bias corrected 95% CIa
Point estimate Lower Upper
The SF-12 v2
 PCS 0.3365 0.2962 0.3806
 PF 0.0425 0.0203 0.0667
 RP 0.2109 0.1781 0.2474
 BP 0.1663 0.1372 0.1967
 GH 0.2458 0.2201 0.2732
Comparing the strength of the mediators (indirect effects)
Bias corrected 95% CIb
Point estimate Lower Upper
 PF versus RP −0.1684 −0.2133 −0.1269
 PF versus BP −0.1238 −0.1634 −0.0845
 PF versus GH −0.2033 −0.2380 −0.1676
 RP versus BP 0.0446 0.0009 0.0909
 RP versus GH −0.0349 −0.0738 0.0076
 BP versus GH −0.1684 −0.2133 −0.1269
BP, bodily pain; GH, general health; PCS, physical component summary; PF, 
physical functioning; RP, role physical; SE, standard error.
aIf the 95% confidence interval (CI) does not contain zero, the mediation 
(indirect effect) is significant.
bIf the 95% confidence interval (CI) does not contain zero, the contrast is 
significant.
cControlling for age, gender, educational attainment, marital status and 
employment status. 
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model. After simultaneously controlling for the socio-demographic 
and other mediators, subjects with one unit change in multi-morbidity 
would have 0.0425-point change in depressive symptoms through the 
PF (16% of the total effect), 0.2109-point change through role physi-
cal (49% of the total effect), 0.1663 through BP (43% of the total 
effect) or 0.2458 though GH (43% of the total effect),.
When the strengths of different mediators were compared, no 
difference was found between the SF-12 v2 GH and RP (as the 95% 
CI contained zero). The mediation effects of SF-12 v2 GH and RP 
were stronger than SF-12v2 BP whilst the effect of the SF-12v2 PF 
was the weakest (Table 2).
Discussion
Summary and main findings
We found that the association between multi-morbidity and depressive 
symptoms was partially mediated by the physical aspects of HRQOL, 
suggesting that multi-morbidity is associated with depressive symptoms 
both directly as well as through the physical aspects of HRQOL. GH 
perception and role limitation due to physical problems were the strong-
est mediators, suggesting that patient’s perception of their GH and the 
amount of limitation to their role functioning had a greater impact on 
the relationship between multi-morbidity and depressive symptoms 
than other aspects of HRQOL. Our findings were supported by the 
theoretical framework that physical illness affects depressive symptoms 
via behavioural and social pathways. Given that HRQOL appears to 
mediate the relationship between multi-morbidity and depressive symp-
toms, for patients with co-morbid depressive and chronic physical ill-
ness, interventions should be directed at improving the physical aspect 
of HRQOL, GH perception, role functioning and PF and to alleviate BP 
to help reduce the impact of the physical co-morbidities on MH.
Discussion of findings and existing literature
The prevalence of chronic disease in our primary care patient sample 
was 50.4% with 25.4% having multi-morbidity which was higher 
than in a general population study in southern China where the 
Figure 3. Models showing the effect of multimorbidity on depressive symptoms as mediated simultaneously by the PF, RP, BP and GH domains 
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prevalence of multi-morbidity was only 11.1% (18). This discrepancy 
was to be expected because the current study was conducted on a 
patient population. An earlier study on primary care patients found 
that multi-morbidity measured by a simple count of chronic health 
problems was associated with the PF, RP, BP and GH domains, and 
the PCS scale, after controlling for confounders (6). Other studies have 
also found that activities of daily living (ADL) (19), instrumental ADL 
(19), self-rated health (19) and pain (20) are associated with depressive 
symptoms. Our findings fit ‘the activity restriction model of depressed 
affect’ proposed by Williamson, suggesting that a decline in normal 
activities are associated with the development of depression (2).
Our study strengthens the findings by Gunn et al. (8), which iden-
tified that self-rated HRQOL partially mediated the link between 
multi-morbidity and depressive symptoms. In this current study, the 
SF-12 v2 was used to measure the different domains of HRQOL 
which can make our mediation model more generalizable than the 
two single items used by Gunn et al. Furthermore, we simultaneously 
put the PF, RP, BP and GH domains into the model to compare the 
strength of the mediation effects of these domains.
Strengths and limitations
There were some strengths and limitations to this study. First, we had a 
large sample size with subjects recruited from a diverse range of settings 
representative of how primary health care is delivered in Hong Kong 
which strengthens the external validity of our results. We also had a 
high response rate. However, as the doctor’s practices used to recruit 
patients were not randomly selected, study population may not be fully 
representative of the Hong Kong primary care population. Future stud-
ies involving a larger or more random selection of practices or studies 
which recruit subjects from the general population by probability sam-
pling may help to strengthen the generalizability of the study findings. 
Second, although the PHQ-9 and the SF-12 v2 have been well validated 
in this setting, all outcome measures were self-reported and may be sub-
ject to recall bias. Third, we used a checklist of eight specific chronic 
physical conditions to measure multi-morbidity which may be consid-
ered an oversimplification. Some might advocate using more sophis-
ticated measures like the Charlson Comorbidity Index, however, such 
measures are complex to use in clinical practice, and may make the find-
ings less generalizable. Also, as our checklist was designed to cover the 
most common chronic conditions encountered in Hong Kong’s primary 
care (13,14) the list may not be applicable to settings with differing 
morbidity profiles. Finally, although mediation analyses on cross-sec-
tional data have been widely used, the model established should not be 
equated with causality that would require a longitudinal design.
Implications for research and practice
Since most chronic diseases are incurable, and given that GH and role 
limitations due to physical problems were the strongest mediators, 
interventions that target GH perception and enhancing functional 
capacity should be trialled such as patient empowerment strategies, 
exercise therapies, relaxation techniques, mindfulness meditation as 
well as physical or occupational therapies aimed at reducing pain 
and improving function. Furthermore, as patients with chronic dis-
ease may have their depressive symptoms masked by co-existing 
somatic complaints, a more holistic management approach may 
allow for better identification of coexisting problems and reduce the 
amount of depressive disorders that are missed in primary care.
To the best of our knowledge, this was the first study to use a 
bootstrapping method to explore the interrelationship between 
multi-morbidity, HRQOL and depressive symptoms. Further research 
is suggested to assess the strength of other potential mediating 
pathways between multi-morbidity and depression to help gain a 
better understanding of how these two sources of global burden may 
be eased. An exploration of the association between multi-morbidity, 
HRQOL and MH using HRQOL as an outcome measure and MH 
symptoms as the mediator could be conducted to better understand 
the relative importance of these complexes and multi-dimensional 
constructs in patients with chronic disease.
Conclusion
Over half of our primary care study population have at least one 
chronic disease with a quarter having multiple co-morbidities. We 
found that patients with more chronic disease tend to have more 
severe depressive symptoms and the relationship is fully mediated 
through physical HRQOL, in particular, GH perception, BP and role 
functioning. Targeting these aspects of HRQOL may help to alleviate 
the impact of multi-morbidity on MH. We hope that the study can 
provide a conceptual framework for intervention delivery.
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